Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
Go back to Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study| (NASDAQ: SKYE) | Delayed: 2.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.23 | 52 Week Low | $ | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.23 | EPS | $ | |||
| Volume | 120 | |||||
